Neptune Insurance Holdings Registers Secondary Offering, Plans Concurrent Share Repurchase
Summary
Neptune Insurance Holdings Inc. filed an S-1 registration statement for a secondary offering of up to 9.6 million Class A common shares by selling stockholders, with the company planning to concurrently repurchase 835,561 shares.
Key Events
-
Secondary Offering Registration
Selling stockholders registered up to 9,608,957 Class A common shares for sale, including an over-allotment option for underwriters. The company will not receive any proceeds from this sale.
-
Concurrent Share Repurchase
Neptune Insurance Holdings Inc. intends to repurchase 835,561 Class A common shares from the underwriters at the offering price, using a combination of cash on hand and borrowings under its revolving credit facility.
-
Institutional Sellers
The selling stockholders are primarily institutional investors, including entities affiliated with Bregal Sagemount and FTV Capital.
-
CEO Not Selling
Trevor Burgess, CEO and Chairman, and his affiliated entities are not selling shares in this offering.
Analysis
This S-1 filing registers a substantial secondary offering by institutional selling stockholders, potentially representing approximately 6.0% of the company's market capitalization. The company will not receive proceeds from the sale by these stockholders. However, Neptune Insurance Holdings Inc. plans to concurrently repurchase 835,561 Class A common shares, using cash and its credit facility, which mitigates the dilutive impact of the offering. The CEO is not selling shares in this transaction. The estimated offering price for fee calculation was $24.45 per share, compared to today's stock price of $29.01, though the final offering price will be determined at the time of sale. This event provides liquidity for existing institutional investors while the company uses its capital to reduce the overall share count entering the market.
At the time of this filing, NP was trading at $29.01 on NYSE in the Finance sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $14.78 to $33.23. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.